MOTS-c: A Research Overview

All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice.

MOTS-c is a small, 16-amino-acid peptide encoded within mitochondrial DNA rather than the cell's main nuclear DNA, making it one of a newer class of signals researchers call mitochondrial-derived peptides. It is studied in metabolic-regulation, insulin-sensitivity, and exercise-physiology research. All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. This page summarizes what the published research shows, and is honest about how early human clinical data still is.

What MOTS-c Is

MOTS-c is encoded within the mitochondrial 12S rRNA region rather than the nuclear genome most other studied peptides come from, which is part of why it draws distinct research interest as a mitochondria-to-cell signaling molecule. Researchers have studied its actions on skeletal muscle in particular, where reported cellular effects touch the folate cycle and downstream purine biosynthesis, ultimately linked to activation of AMPK, a central regulator of cellular energy balance. Any MOTS-c material supplied by BioRegen is handled strictly as a lab chemical for laboratory and educational research, not for use in people or animals.

What the Research Shows

Human clinical data is early and limited. The published evidence base is predominantly preclinical, conducted in cell and animal models. A foundational 2015 study reported that MOTS-c administration improved insulin sensitivity and reduced measures of obesity and insulin resistance in aged and diet-induced obese mice, with effects reported on multiple metabolic pathways involved in obesity and type 2 diabetes models. A later 2021 study described MOTS-c as an exercise-induced regulator linked to age-dependent physical decline and muscle homeostasis in mouse models, reporting that it could regulate nuclear genes tied to metabolism and skeletal-muscle adaptation. Both studies are animal research; neither establishes an effect in humans.

Community Discussion and Its Limits

MOTS-c is discussed in longevity and performance communities, often framed around its animal-model links to exercise physiology and metabolic health. That is unverified anecdotal commentary, not controlled data, and not a BioRegen claim. As with several other mitochondrial and longevity-adjacent peptides, the active preclinical research program has generated public interest well ahead of any equivalent human clinical evidence.

Regulatory Status and Handling

MOTS-c is not FDA-approved for human use. BioRegen supplies MOTS-c reference material strictly for laboratory and educational research, not for human use. As a lab chemical, it is typically supplied as a lyophilized (freeze-dried) powder that should be kept cold and reconstituted only immediately before use in a laboratory setting. For a general, lab-level overview of how researchers prepare peptides, see our overview on how to reconstitute peptides. These notes cover laboratory handling only and are not directions for use in people or animals.

Frequently Asked Questions

What makes MOTS-c different from other studied peptides?

It is encoded in mitochondrial DNA rather than the cell's nuclear DNA, placing it in a research category called mitochondrial-derived peptides, studied for signaling between mitochondria and the rest of the cell.

Does MOTS-c have human clinical trial data?

Human clinical data is early and limited. The published research base is predominantly preclinical, in animal and cell models examining metabolism, insulin sensitivity, and exercise physiology.

Is MOTS-c approved for any use in people?

No. MOTS-c is not FDA-approved for human use, and the material BioRegen supplies is a lab chemical intended strictly for laboratory and educational research.

Continue Your Research

To explore related compounds, use our research finder or browse the metabolic and energy research category. New to sourcing reference materials? Read the BioRegen research guide and create a free account for 10% off your first order.

Selected research references

• The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance. Cell Metabolism, 2015.
• MOTS-c Is an Exercise-Induced Mitochondrial-Encoded Regulator of Age-Dependent Physical Decline and Muscle Homeostasis. Nature Communications, 2021.

Reference metadata sourced via Crossref.

All information on this page is provided strictly for laboratory and educational research purposes. No compound referenced is approved for human or veterinary use, none of it is intended to diagnose, treat, cure, or prevent any disease, and nothing here constitutes medical advice.